` GRDN (Guardian Pharmacy Services Inc) vs S&P 500 Comparison - Alpha Spread

GRDN
vs
S&P 500

Over the past 12 months, GRDN has outperformed S&P 500, delivering a return of 23% compared to the S&P 500's 22% growth.

Stocks Performance
GRDN vs S&P 500

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
GRDN vs S&P 500

Loading
GRDN
S&P 500
Difference

Performance By Year
GRDN vs S&P 500

Loading
GRDN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Guardian Pharmacy Services Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Guardian Pharmacy Services Inc
Glance View

Market Cap
1.2B USD
Industry
N/A

Guardian Pharmacy Services Inc. stands as a significant player in the world of pharmacy services, particularly as an innovator in the long-term care sector. Founded in 2004 and headquartered in Atlanta, Georgia, the company operates with a keen focus on providing personalized pharmacy solutions to assisted living facilities, skilled nursing centers, and other long-term care environments. It does so through a decentralized model—establishing locally-owned and operated pharmacies. This strategy allows Guardian to maintain a unique blend of broad corporate reach and personalized care, catering to the specific needs of each community it serves. This localized approach ensures high-quality service and enhances customer relationships, which are crucial in this industry. The company's revenue model revolves around this tailored service delivery. Guardian Pharmacy Services generates income primarily through medication dispensing, consulting services, and specialized packaging. By creating partnerships with local entrepreneurs to manage their facilities, they leverage local insights and expertise, ensuring operations align with regional regulatory requirements and healthcare standards. Guardian further solidifies its standing by utilizing advanced technology systems that streamline medication management, ensuring efficiency, and reducing errors. This commitment to both technological innovation and localized service cements Guardian’s position as a trusted ally in the healthcare continuum, driving its profitability through enhanced service and dependability.

GRDN Intrinsic Value
21.228 USD
Undervaluation 7%
Intrinsic Value
Price
G
Back to Top